The FDA is preparing to scale back on routine drug inspections following widespread layoffs in support staff, multiple officials told CBS News. Around 170 employees were cut from the FDA's Office of Inspections and Investigations, according to two health officials who were not authorized to comment publicly. The HHS has said broader layoffs ordered by [...] The post FDA planning fewer drug inspections due to layoffs appeared first on Becker's Hospital Review | Healthcare News & Analysis.